Zepbound is approved by the FDA as a weight loss management treatment for people with obesity or those who are overweight with at least one weight-related condition such as high blood pressure
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
All the participants underwent a series of tests to measure their weight, blood glucose, plasma insulin and glucagon levels
Aim for roughly 2535 grams of protein per meal, ideally from foods like lean meats, Greek yogurt, or cottage cheese
Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism
While there is no absolute contraindication, alcohol can: Increase nausea and gastrointestinal distress Contribute empty calories that undermine weight management efforts Potentially increase the risk of hypoglycemia in patients also taking diabetes medications Impair judgment regarding portion control and food choices Potentially increase pancreatitis risk, especially with heavy consumption Patients should discuss alcohol use with their healthcare provider and, if consuming alcohol, do so in moderation (defined as up to one drink per day for women and up to two drinks per day for men)
